Glucocorticoid/NN
receptors/NNS
are/VBP
down-regulated/VBN
in/IN
inflamed/JJ
colonic/JJ
mucosa/NN
but/CC
not/RB
in/IN
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
from/IN
patients/NNS
with/IN
inflammatory/JJ
bowel/NN
disease/NN
[/(
see/VB
comments/NNS
]/)

BACKGROUND/NN
:/:
Growing/VBG
evidence/NN
indicates/VBZ
that/IN
the/DT
immune/JJ
system/NN
and/CC
the/DT
hypothalamic-pituitary-adrenal/JJ
system/NN
are/VBP
linked/VBN
by/IN
several/JJ
mechanisms/NNS
,/,
for/IN
example/NN
intracellular/JJ
glucocorticoid/NN
receptors/NNS
(/(
hGR/NN
)/)
./.
=====
Glucocorticoids/NNS
are/VBP
the/DT
standard/JJ
treatment/NN
of/IN
acute/JJ
attacks/NNS
of/IN
inflammatory/JJ
bowel/NN
disease/NN
(/(
IBD/NN
)/)
./.
=====
Binding/NN
of/IN
glucocorticoids/NNS
to/TO
hGR/NN
down-regulates/VBZ
the/DT
transcription/NN
of/IN
inflammatory/JJ
genes/NNS
that/WDT
can/MD
propagate/VB
IBD/NN
./.
=====
PATIENTS/NNS
AND/CC
METHODS/NNS
:/:
IBD/NN
patients/NNS
were/VBD
either/RB
treated/VBN
with/IN
5-60/CD
mg/NN
of/IN
prednisolone/NN
for/IN
more/JJR
than/IN
1/CD
week/NN
or/CC
were/VBD
without/IN
glucocorticoid/NN
treatment/NN
for/IN
more/JJR
than/IN
4/CD
weeks/NNS
./.
=====
hGR/NN
levels/NNS
were/VBD
determined/VBN
from/IN
isolated/VBN
cytosol/NN
of/IN
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
(/(
PBMCs/NNS
)/)
or/CC
mucosal/JJ
biopsies/NNS
using/VBG
a/DT
radioassay/NN
with/IN
[3H]-dexamethasone/NN
./.
=====
Interleukin/NN
(/(
IL/NN
)/)
6/CD
levels/NNS
were/VBD
determined/VBN
by/IN
enzyme-linked/JJ
immunosorbent/JJ
assay/NN
(/(
ELISA/NN
)/)
./.
=====
RESULTS/NNS
:/:
The/DT
systemic/JJ
(/(
PBMC/NN
)/)
hGR/NN
levels/NNS
of/IN
corticosteroid-treated/JJ
IBD/NN
patients/NNS
were/VBD
significantly/RB
lower/JJR
than/IN
those/DT
of/IN
control/JJ
subjects/NNS
(/(
59.6/CD
+/-/CC
57.1/CD
dpm/NN
mg-1/NN
cytosol/NN
protein/NN
vs./CC
=====
227.0/CD
+/-/CC
90.8/CD
dpm/NN
mg-1/NN
cytosol/NN
protein/NN
,/,
P/NN
=/JJ
0.007/CD
)/)
and/CC
IBD/NN
patients/NNS
not/RB
receiving/VBG
glucocorticoid/NN
treatment/NN
(/(
179.7/CD
+/-/CC
171.3/CD
dpm/NN
mg-1/NN
cytosol/NN
protein/NN
,/,
P/NN
=/JJ
0.002/CD
)/)
./.
=====
Systemic/JJ
hGR/NN
levels/NNS
in/IN
untreated/JJ
IBD/NN
patients/NNS
did/VBD
not/RB
differ/VB
significantly/RB
from/IN
those/DT
in/IN
control/JJ
subjects/NNS
./.
=====
In/IN
patients/NNS
with/IN
connective/JJ
tissue/NN
diseases/NNS
,/,
systemic/JJ
hGR/NN
levels/NNS
were/VBD
also/RB
found/VBN
to/TO
be/VB
decreased/VBN
in/IN
the/DT
absence/NN
of/IN
glucocorticoid/NN
treatment/NN
./.
=====
Systemic/JJ
hGR/NN
levels/NNS
in/IN
patients/NNS
with/IN
Crohn/NN
's/POS
disease/NN
(/(
CD/NN
)/)
treated/VBN
with/IN
steroids/NNS
(/(
66.6/CD
+/-/CC
61.0/CD
dpm/NN
mg-1/NN
cytosol/NN
protein/NN
)/)
were/VBD
not/RB
different/JJ
from/IN
those/DT
in/IN
patients/NNS
with/IN
ulcerative/JJ
colitis/NN
(/(
UC/NN
)/)
(/(
56.1/CD
+/-/CC
51.6/CD
dpm/NN
mg-1/NN
cytosol/NN
protein/NN
)/)
./.
=====
In/IN
contrast/NN
to/TO
these/DT
findings/NNS
,/,
mucosal/JJ
hGR/NN
levels/NNS
were/VBD
significantly/RB
decreased/VBN
in/IN
both/DT
steroid-treated/JJ
(/(
18.0/CD
+/-/CC
15.5/CD
)/)
and/CC
not/RB
steroid-treated/JJ
(/(
37.8/CD
+/-/CC
30.5/CD
)/)
patients/NNS
compared/VBN
with/IN
control/JJ
subjects/NNS
(/(
125.6/CD
+/-/CC
97.1/CD
;/:
P/NN
=/JJ
0.00009/CD
and/CC
P/NN
=/JJ
0.0008/CD
respectively/RB
)/)
./.
=====
IL-6/NN
levels/NNS
in/IN
all/DT
IBD/NN
groups/NNS
with/IN
and/CC
without/IN
steroids/NNS
were/VBD
significantly/RB
different/JJ
from/IN
those/DT
in/IN
control/JJ
subjects/NNS
./.
=====
CONCLUSION/NN
:/:
In/IN
IBD/NN
there/EX
is/VBZ
no/DT
difference/NN
in/IN
systemic/JJ
hGR/NN
levels/NNS
between/IN
not/RB
steroid-treated/JJ
patients/NNS
and/CC
control/JJ
subjects/NNS
,/,
in/IN
spite/NN
of/IN
inflammatory/JJ
activity/NN
(/(
IL-6/NN
)/)
./.
=====
Mucosal/JJ
hGR/NN
levels/NNS
were/VBD
decreased/VBN
independently/RB
of/IN
treatment/NN
,/,
probably/RB
leading/VBG
to/TO
a/DT
decreased/VBN
protection/NN
against/IN
NF-kappaB/NN
action/NN
in/IN
the/DT
intestinal/JJ
mucosa/NN
./.